Introduction From a characterization perspective, synthetic vs recombinant peptide drug characterization differs primarily in the assessment of process-related impurity profiles, […]
Introduction Charge Variant Profiling by icIEF identified a critical comparability failure in an adalimumab biosimilar candidate by detecting an unacceptable
Introduction: NMR vs LC-MS for Peptide Characterization is not simply a question of choosing the more advanced instrument — it’s
Introduction: Peptide Impurity Profiling by LC-MS is an advanced analytical approach used to detect and characterize structurally related impurities in
Introduction Charge Variant Analysis of Therapeutic Peptides is a critical analytical framework for profiling, quantifying, and monitoring charged proteoforms and
Introduction Chiral Purity Testing and D-Amino Acid Quantification in a synthetic octapeptide active pharmaceutical ingredient (API) requires high-resolution liquid chromatography
Introduction Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) serves as a label-free biophysical approach for investigating peptide conformational dynamics, solvent accessibility, and
Introduction Quantitative NMR (qNMR) for peptide reference standard characterization is an increasingly important analytical approach for establishing the quantitative content,
Introduction Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) is a high-resolution, solution-phase analytical technique that enables dynamic characterization of backbone hydrogen-bonding patterns
Introduction: Therapeutic peptide characterization for NDA and ANDA submissions sits at the intersection of analytical chemistry and regulatory strategy, and
